Bio-IT World July 16, 2024
Deborah Borfitz

Artificial intelligence (AI) is the new frontier in biomedical research, with large language models changing the way science is done from writing code and brainstorming research ideas to helping do research and conducting literature reviews. In some of its latest applications, generative AI has been used in designing molecules with insights produced at a scale and speed not possible with traditional deep learning methods alone, according to Marinka Zitnik, Ph.D., assistant professor of biomedical informatics at Harvard Medical School.

The potential of AI to aid in the development of new drugs to cure disease is enormous given the size of the chemical universe (1060 chemical compounds) relative to the tiny fraction (105) that has been synthesized...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Partnerships, Pharma / Biotech, Technology, Trends
First Comprehensive Review of SMA Drugs Offers Long-Term Insights, Outcome Gaps
Health Rounds: Next Generation Lilly Weight-loss Drug Shows Added Heart, Liver Benefits
Drugmaker might be 1st healthcare company to top $1 trillion valuation
Pharma Pulse 9/5/24: Legal Advice for DSCSA Compliance Teams, Pharmacy Students Discuss Learning Through Social Media Platforms & more
RNA treatment shows promise for enhancing memory and reducing anxiety

Share This Article